Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus

European Journal of Neuroscience

Volumn 37, Issue 3, 2013, Pages 479-490

  Barr, Jeffrey L ^a,b   Scholl, Jamie L ^a   Solanki, Rajeshwari R ^a   Watt, Michael J ^a   Lowry, Christopher A ^c   Renner, Kenneth J ^a,d   Forster, Gina L ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d University of South Dakota   (United States)

Author keywords

Microdialysis; Organic cation transporter; Rat; Selective serotonin reuptake inhibitor; Serotonin transporter

Indexed keywords

AMPHETAMINE; ORGANIC CATION TRANSPORTER 3; SEROTONIN; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RAT; SEROTONIN BLOOD LEVEL; SEROTONIN CLEARANCE; SEROTONIN SYNTHESIS; SEROTONINERGIC TRANSMISSION; VENTRAL HIPPOCAMPUS; WITHDRAWAL SYNDROME;

AMPHETAMINE; ANIMALS; GENE EXPRESSION; HIPPOCAMPUS; MALE; ORGANIC CATION TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPTIC TRANSMISSION; TRYPTOPHAN HYDROXYLASE;

EID: 84873316532     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12050     Document Type: Article

References (80)

1. Amphoux, A., Vialou, V., Drescher, E., Bruss, M., Cour Mannoury La, C., Rochat, C., Millan, M.J., Giros, B., Bonisch, H. & Gautron, S. (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology, 50, 941-952.
2. Azmitia, E.C. & Segal, M. (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179, 641-667.
3. Badoer, E., Wurth, H., Turck, D., Qadri, F., Itoi, K., Dominiak, P. & Unger, T. (1989) The, K+-induced increases in noradrenaline & dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol., 339, 54-59.
4. Baganz, N.L., Horton, R.E., Calderon, A.S., Owens, W.A., Munn, J.L., Watts, L.T., Koldzic-Zivanovic, N., Jeske, N.A., Koek, W., Toney, G.M. & Daws, L.C. (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc. Natl. Acad. Sci. USA, 105, 18976-18981.
5. Barr, J.L. & Forster, G.L. (2011) Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone & altered by chronic amphetamine treatment. Neuroscience, 182, 105-114.
6. Barr, J.L., Renner, K.J. & Forster, G.L. (2010) Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus. Neuropharmacology, 59, 395-405.
7. Benmansour, S., Deltheil, T., Piotrowski, J., Nicolas, L., Reperant, C., Gardier, A.M., Frazer, A. & David, D.J. (2008) Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur. J. Pharmacol., 587, 90-98.
8. Blakely, R.D. & Bauman, A.L. (2000) Biogenic amine transporters: regulation in flux. Curr. Opin. Neurobiol., 10, 328-336.
9. Blakely, R.D., Defelice, L.J. & Galli, A. (2005) Biogenic amine neurotransmitter transporters: just when you thought you knew them. Physiology (Bethesda), 20, 225-231.
10. Bonhomme, N., Cador, M., Stinus, L., Le Moal, M. & Spampinato, U. (1995) Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res., 675, 215-223.
11. Burke, A.R., Watt, M.J. & Forster, G.L. (2011) Adolescent social defeat increases adult amphetamine conditioned place preference and alters D2 dopamine receptor expression. Neuroscience, 197, 269-279.
12. Daws, L.C. (2009) Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol. Ther., 121, 89-99.
13. Daws, L.C., Toney, G.M., Gerhardt, G.A. & Frazer, A. (1998) In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J. Pharmacol. Exp. Ther., 286, 967-976.
14. Daws, L.C., Montanez, S., Munn, J.L., Owens, W.A., Baganz, N.L., Boyce- Rustay, J.M., Millstein, R.A., Wiedholz, L.M., Murphy, D.L. & Holmes, A. (2006) Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J. Neurosci., 26, 6431-6438.
15. Duan, H. & Wang, J. (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J. Pharmacol. Exp. Ther., 335, 743-753.
16. Evans, A.K., Heerkens, J.L. & Lowry, C.A. (2009) Acoustic stimulation in vivo and corticotropin-releasing factor in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus. Neurosci. Lett., 455, 36-41.
17. Feng, N., Mo, B., Johnson, P.L., Orchinik, M., Lowry, C.A. & Renner, K.J. (2005) Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res., 1063, 69-76.
18. Feng, N., Telefont, M., Kelly, K.J., Orchinik, M., Forster, G.L., Renner, K.J. & Lowry, C.A. (2009) Local perfusion of corticosterone in the rat medial hypothalamus potentiates D-fenfluramine-induced elevations of extracellular 5-HT concentrations. Horm. Behav., 56, 149-157.
19. Forster, G.L., Feng, N., Watt, M.J., Korzan, W.J., Mouw, N.J., Summers, C.H. & Renner, K.J. (2006) Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience, 141, 1047-1055.
20. Forster, G.L., Pringle, R.B., Mouw, N.J., Vuong, S.M., Watt, M.J., Burke, A.R., Lowry, C.A., Summers, C.H. & Renner, K.J. (2008) Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur. J. Neurosci., 28, 299-310.
21. Gainetdinov, R.R. & Caron, M.G. (2003) Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol., 43, 261-284.
22. Gasser, P.J., Lowry, C.A. & Orchinik, M. (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J. Neurosci., 26, 8758-8766.
23. Gasser, P.J., Orchinik, M., Raju, I. & Lowry, C.A. (2009) Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J. Comp. Neurol., 512, 529-555.
24. Gorboulev, V., Ulzheimer, J.C., Akhoundova, A., Ulzheimer-Teuber, I., Karbach, U., Quester, S., Baumann, C., Lang, F., Busch, A.E. & Koepsell, H. (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol., 16, 871-881.
25. Gossop, M. (2009) Review: limited evidence to support pharmacological therapy for amphetamine withdrawal. Evid. Based Ment. Health, 12, 122.
26. Graeff, F.G., Guimaraes, F.S., De Andrade, T.G. & Deakin, J.F. (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav., 54, 129-141.
27. Gründemann, D., Babin-Ebell, J., Martel, F., Ording, N., Schmidt, A. & Schömig, E. (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J. Biol. Chem., 272, 10408-10413.
28. Guimaraes, F., Del Bel, E.A., Padovan, C.M., Netto, S.M. & de Almeida, R.T. (1993) Hippocampal 5-HT receptors and consolidation of stressful memories. Behav. Brain Res., 58, 133-139.
29. Heidenreich, B.A. & Rebec, G.V. (1989) Serotonergic dorsal raphe neurons: changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration. Neurosci. Lett., 103, 81-86.
30. Heidenreich, B.A., Basse-Tomusk, A.E. & Rebec, G.V. (1987) Serotonergic dorsal raphe neurons: subsensitivity to amphetamine with long-term treatment. Neuropharmacology, 26, 719-724.
31. Hilber, B., Scholze, P., Dorostkar, M.M., Sandtner, W., Holy, M., Boehm, S., Singer, E.A. & Sitte, H.H. (2005) Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamines and non-amphetamines. Neuropharmacology, 49, 811-819.
32. Hirano, K., Kimura, R., Sugimoto, Y., Yamada, J., Uchida, S., Kato, Y., Hashimoto, H. & Yamada, S. (2005) Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br. J. Pharmacol., 144, 695-702.
33. Holmes, A., Lit, Q., Murphy, D.L., Gold, E. & Crawley, J.N. (2003) Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav., 2, 365-380.
34. Jennings, K.A., Loder, M.K., Sheward, W.J., Pei, Q., Deacon, R.M., Benson, M.A., Olverman, H.J., Hastie, N.D., Harmar, A.J., Shen, S. & Sharp, T. (2006) Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission. J. Neurosci., 26, 8955-8964.
35. Joca, S.R., Padovan, C.M. & Guimaraes, F.S. (2003) Activation of post-synaptic 5-HT(1A) receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res., 978, 177-184.
36. Johnston, C.A. & Moore, K.E. (1983) Measurement of 5-hydroxytryptamine synthesis and metabolism in selected discrete regions of the rat brain using high performance liquid chromatography and electrochemical detection: pharmacological manipulations. J. Neural Transm., 57, 49-63.
37. Kagamiishi, Y., Yamamoto, T. & Watanabe, S. (2003) Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor. Brain Res., 991, 212-221.
38. Kalueff, A.V., Fox, M.A., Gallagher, P.S. & Murphy, D.L. (2007) Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav., 6, 389-400.
39. Keck, M.E., Sartori, S.B., Welt, T., Muller, M.B., Ohl, F., Holsboer, F., Landgraf, R. & Singewald, N. (2005) Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J. Neurochem., 92, 1170-1179.
40. Kitaichi, K., Fukuda, M., Nakayama, H., Aoyama, N., Ito, Y., Fujimoto, Y., Takagi, K. & Hasegawa, T. (2005) Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci. Lett., 382, 195-200.
41. Knych, E.T. & Eisenberg, R.M. (1979) Effect of amphetamine on plasma corticosterone in the conscious rat. Neuroendocrinology, 29, 110-118.
42. Koepsell, H., Lips, K. & Volk, C. (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res., 24, 1227-1251.
43. Koob, G.F. & Le Moal, M. (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacol., 24, 97-129.
44. Linthorst, A.C.E., Peñalva, R.G., Flachskamm, C., Holsboer, F. & Reul, J.M.H.M. (2002) Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur. J. Neurosci., 16, 2441-2452.
45. Lukkes, J.L., Watt, M.J., Lowry, C.A. & Forster, G.L. (2009) Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents. Front. Behav. Neurosci., 3, 1-12.
46. Maggi, C.A. & Meli, A. (1986) Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 1: general considerations. Experientia, 42, 109-114.
47. Miguez, J.M., Paz-Valinas, L., Miguez, I. & Aldegunde, M. (2002) Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study. Naunyn Schmiedebergs Arch. Pharmacol., 365, 378-387.
48. Montanez, S., Daws, L.C., Gould, G.G., Gerhardt, G.A. & Frazer, A. (2002) Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Res., 955, 236-244.
49. O'Reilly, K.C., Trent, S., Bailey, S.J. & Lane, M.A. (2007) 13-cis-Retinoic acid alters intracellular serotonin, increases 5-HT1A receptor, and serotonin reuptake transporter levels in vitro. Exp. Biol. Med., 232, 1195-1203.
50. Paxinos, G. & Watson, C. (1996) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic Press, New York.
51. Pringle, R.B., Mouw, N.J., Lukkes, J.L. & Forster, G.L. (2008) Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus. Neurosci. Res., 62, 62-65.
52. Qian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L.J. & Blakely, R.D. (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci., 17, 45-57.
53. Ramamoorthy, S. & Blakely, R.D. (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science, 285, 763-766.
54. Ramsey, I.S. & DeFelice, L.J. (2002) Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor. J. Biol. Chem., 277, 14475-14482.
55. Renner, K.J., Krey, L.C. & Luine, V.N. (1987) Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat. Brain Res. Bull., 19, 195-202.
56. Romanelli, F. & Smith, K.M. (2006) Clinical effects and management of methamphetamine abuse. Pharmacotherapy, 26, 1148-1156.
57. Rothman, R.B., Jayanthi, S., Wang, X., Dersch, C.M., Cadet, J.L., Prisinzano, T., Rice, K.C. & Baumann, M.H. (2003) High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse, 50, 233-239.
58. Rothman, R.B., Jayanthi, S., Cadet, J.L., Wang, X., Dersch, C.M. & Baumann, M.H. (2004) Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression. Ann. NY Acad. Sci., 1025, 151-161.
59. Schmitt, A., Mossner, R., Gossmann, A., Fischer, I.G., Gorboulev, V., Murphy, D.L., Koepsell, H. & Lesch, K.P. (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J. Neurosci. Res., 71, 701-709.
60. Scholl, J.L., Feng, N., Watt, M.J., Renner, K.J. & Forster, G.L. (2009) Individual differences in amphetamine sensitization, behavior and central monoamines. Physiol. Behav., 96, 493-504.
61. Scholl, J.L., Renner, K.J., Forster, G.L. & Tejani-Butt, S. (2010a) Central monoamine levels differ between rat strains used in studies of depressive behavior. Brain Res., 1355, 41-51.
62. Scholl, J.L., Vuong, S.M. & Forster, G.L. (2010b) Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala. Eur. J. Pharmacol., 644, 80-87.
63. Schömig, E., Lazar, A. & Gründemann, D. (2006) Extraneuronal monoamine transporter & organic cation transporters 1 & 2: a review of transport efficiency. Handb. Exp. Pharmacol., 175, 151-180.
64. Schuldiner, S., Steiner-Mordoch, S., Yelin, R., Wall, S.C. & Rudnick, G. (1993) Amphetamine derivatives interact with both plasma membrane & secretory vesicle biogenic amine transporters. Mol. Pharmacol., 44, 1227-1231.
65. Seidel, S., Singer, E.A., Just, H., Farhan, H., Scholze, P., Kudlacek, O., Holy, M., Koppatz, K., Krivanek, P., Freissmuth, M. & Sitte, H.H. (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol. Pharmacol., 67, 140-151.
66. Sexton, T.J., McEvoy, C. & Neumaier, J.F. (1999) (+) 3, 4-Methylenedioxymethamphetamine ('Ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain. Mol. Psychiatry, 4, 572.
67. Shoptaw, S.J., Kao, U., Heinzerling, K. & Ling, W. (2009) Treatment for amphetamine withdrawal. Cochrane Database Syst. Rev., 2, CD003021.
68. Steiner, J.A., Carneiro, A.M. & Blakely, R.D. (2008) Going with the flow: trafficking-dependent & -independent regulation of serotonin transport. Traffic, 9, 1393-1402.
69. Storey, J.D., Robertson, D.A., Beattie, J.E., Reid, I.C., Mitchell, S.N. & Balfour, D.J.K. (2006) Behavioural & neurochemical responses evoked by repeated exposure to an elevated open platform. Behav. Brain Res., 166, 220-229.
70. Swerdlow, N.R., Koob, G.F., Cador, M., Lorang, M. & Hauger, R.L. (1993) Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol. Biochem. Behav., 45, 629-637.
71. Tatsumi, M., Groshan, K., Blakely, R.D. & Richelson, E. (1997) Pharmacological profile of antidepressants & related compounds at human monoamine transporters. Eur. J. Pharmacol., 340, 249-258.
72. Trillat, A.C., Malagie, I., Scearce, K., Pons, D., Anmella, M.C., Jacquot, C., Hen, R. & Gardier, A.M. (1997) Regulation of serotonin release in the frontal cortex & ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies. J. Neurochem., 69, 2019-2025.
73. Vuong, S.M., Oliver, H.A., Scholl, J.L., Oliver, K.M. & Forster, G.L. (2010) Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behav. Brain Res., 208, 278-281.
74. Wang, X., Baumann, M.H., Xu, H. & Rothman, R.B. (2004) 3, 4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse, 53, 240-248.
75. Wang, X., Baumann, M.H., Xu, H., Morales, M. & Rothman, R.B. (2005) (+/-)-3, 4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J. Pharmacol. Exp. Ther., 314, 1002-1012.
76. Williams, M.T., Schaefer, T.L., Ehrman, L.A., Able, J.A., Gudelsky, G.A., Sah, R. & Vorhees, C.V. (2005) 3, 4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res., 1039, 97-107.
77. Wu, X., Kekuda, R., Huang, W., Fei, Y.J., Leibach, F.H., Chen, J., Conway, S.J. & Ganapathy, V. (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem., 273, 32776-32786.
78. Wultsch, T., Grimberg, G., Schmitt, A., Painsipp, E., Wetzstein, H., Breitenkamp, A.F., Gründemann, D., Schömig, E., Lesch, K.P., Gerlach, M. & Reif, A. (2009) Decreased anxiety in mice lacking the organic cation transporter 3. J. Neural Transm., 116, 689-697.
79. Zeeb, F., Wong, A. & Winstanley, C. (2012) Differential effects of environmental enrichment, social-housing, and isolation-rearing on a rat gambling task: dissociations between impulsive action and risky decision-making. Psychopharmacology, PMID: 22864967 [Epub ahead of print].
80. Zhu, H.J., Appel, D.I., Grundemann, D. & Markowitz, J.S. (2010) Interaction of organic cation transporter 3 (SLC22A3) and amphetamine. J. Neurochem., 114, 142-149.